Mirae Asset Global stated on April 28 that it was renegotiating with China’s Anbang Insurance to delay the closing date of a US$5.8 billion deal and that it has nothing to do with problems with capital financing, but is because of other requirements that remain unfulfilled.
Featured News
House Panel Alleges CVS Used Contracts to Suppress Pharmacy Competition
Jan 21, 2026 by
CPI
AI Is Changing M&A as Regulators Target ‘Killer Acquisitions’ and Data Control
Jan 21, 2026 by
CPI
Epic Games Brings in Veteran Tech Lawyer as Legal Chief
Jan 21, 2026 by
CPI
Deepfakes-as-a-Service Creating New Fraud Risks for Enterprises
Jan 21, 2026 by
CPI
Mississippi Medical Board Faces Antitrust Challenge Over Nurse-Midwife Practice Rules
Jan 21, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Recidivism
Jan 21, 2026 by
CPI
Recidivism, Multiple Offending, and Serial Offending in Antitrust
Jan 21, 2026 by
Gregory Werden
Antitrust Recidivism: Why Repeat Cases Appear, and Why True Reoffending Is Rare in the United States
Jan 21, 2026 by
Lisa M. Phelan, Megan S. Golden, Adrienne Irmer & Nina Worth
99 Antitrust Problems – Is Recidivism One?
Jan 21, 2026 by
Brian A. Ratner & Kartik S. Madiraju
Holding A Cat by the Tail: A View of Cartel Recidivism in U.S. Antitrust Enforcement
Jan 21, 2026 by
Mark & KaDee L. Ru